Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3520 ARTÍCULOS , VIENDO DEL 3241 AL 3255

Hashimoto's encephalopathy presenting with micrographia as a typical feature of parkinsonism

Inoue K, Kitamura J, Yoneda M, Imamura E, Tokinobu H.

Neurol Sci. 2012 Apr;33(2):395-7. doi: 10.1007/s10072-011-0750-x. Epub 2011 Sep 6.

G protein-coupled receptor kinases: more than just kinases and not only for GPCRs

Gurevich EV, Tesmer JJ, Mushegian A, Gurevich VV.

Pharmacol Ther. 2012 Jan;133(1):40-69. doi: 10.1016/j.pharmthera.2011.08.001. Epub 2011 Aug 26.

Motor improvement with bilateral subthalamic nucleus deep brain stimulation in a patient with levodopa-responsive secondary parkinsonism

Kotagal V, Patil PG, Chou KL.

Parkinsonism Relat Disord. 2012 Jan;18(1):79-81. doi: 10.1016/j.parkreldis.2011.08.014. Epub 2011 Sep 7.

Aripiprazole associated with acute dystonia, akathisia, and parkinsonism in a single patient

Saddichha S, Kumar R, Babu GN, Chandra P.

J Clin Pharmacol. 2012 Sep;52(9):1448-9. doi: 10.1177/0091270011414573. Epub 2011 Sep 8.

Cortical activities associated with voluntary movements and involuntary movements

Shibasaki H.

Clin Neurophysiol. 2012 Feb;123(2):229-43. doi: 10.1016/j.clinph.2011.07.042. Epub 2011 Sep 8.

A randomized, double-blind, placebo-controlled trial of safinamide as add-on therapy in early Parkinson's disease patients

Stocchi F, Borgohain R, Onofrj M, Schapira AH, Bhatt M, Lucini V, Giuliani R, Anand R; Study 015 Investigators.

Mov Disord. 2012 Jan;27(1):106-12. doi: 10.1002/mds.23954. Epub 2011 Sep 12.

Validation of the non-motor symptoms questionnaire (NMS-Quest)

Romenets SR, Wolfson C, Galatas C, Pelletier A, Altman R, Wadup L, Postuma RB.

Parkinsonism Relat Disord. 2012 Jan;18(1):54-8. doi: 10.1016/j.parkreldis.2011.08.013. Epub 2011 Sep 14.

Accuracy of algorithms to predict accessory pathway location in children with Wolff-Parkinson-White syndrome

Wren C, Vogel M, Lord S, Abrams D, Bourke J, Rees P, Rosenthal E.

Heart. 2012 Feb;98(3):202-6. doi: 10.1136/heartjnl-2011-300269. Epub 2011 Sep 13.

Pharmacological treatment of deep brain stimulation-induced hypomania leads to clinical remission while preserving motor benefits

Schilbach L, Weiss PH, Kuhn J, Timmermann L, Klosterkötter J, Huff W.

Neurocase. 2012;18(2):152-9. doi: 10.1080/13554794.2011.568502. Epub 2011 Sep 15.

Relationships between deep brain stimulation and impulse control disorders in Parkinson's disease, with a literature review

Shotbolt P, Moriarty J, Costello A, Jha A, David A, Ashkan K, Samuel M.

Parkinsonism Relat Disord. 2012 Jan;18(1):10-6. doi: 10.1016/j.parkreldis.2011.08.016. Epub 2011 Sep 14.

Role of microRNAs in central nervous system development and pathology

Meza-Sosa KF, Valle-García D, Pedraza-Alva G, Pérez-Martínez L.

J Neurosci Res. 2012 Jan;90(1):1-12. doi: 10.1002/jnr.22701. Epub 2011 Sep 15.

Combined pallidal and subthalamic nucleus stimulation in sporadic dystonia-parkinsonism

Wöhrle JC, Blahak C, Capelle HH, Fogel W, Bäzner H, Krauss JK.

J Neurosurg. 2012 Jan;116(1):95-8. doi: 10.3171/2011.8.JNS101552. Epub 2011 Sep 16.

Reconsidering GHB: orphan drug or new model antidepressant?

Bosch OG, Quednow BB, Seifritz E, Wetter TC.

J Psychopharmacol. 2012 May;26(5):618-28. doi: 10.1177/0269881111421975. Epub 2011 Sep 17.

Effects of peripheral lymphocyte subpopulations and the clinical correlation with Parkinson's disease

Niwa F, Kuriyama N, Nakagawa M, Imanishi J.

Geriatr Gerontol Int. 2012 Jan;12(1):102-7. doi: 10.1111/j.1447-0594.2011.00740.x. Epub 2011 Sep 19.

Molecular network of microRNA targets in Alzheimer's disease brains

Satoh J.

Exp Neurol. 2012 Jun;235(2):436-46. doi: 10.1016/j.expneurol.2011.09.003. Epub 2011 Sep 16.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias